Technology

Boston Scientific changed the name of the company's Liberté Bare-Metal coronary stent to VeriFLEX in September 2009....

Invatec's Mo.Ma Ultra Proximal Cerebral Protection Device is used during carotid artery stenting (CAS) to reduce and capture debris released during the stenting procedure to prevent it from traveling ...

Cordis Corp. offers the 2.25 mm CYPHER Sirolimus-Eluting Coronary Stent, which is indicated for treatment of coronary blockages in small vessels.

...

The GORE VIABAHN Endoprosthesis, a self-expanding, covered, stent, is offered in diameters from 6-13 mm for the treatment of peripheral arterial disease (PAD) in the iliac artery.

...

Boston Scientific's TAXUS Liberte Long Paclitaxel-Eluting Coronary Stent System is designed for long lesions....

Effient (prasugrel) tablets are indicated for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndromes who are managed with percutaneous...

Boston Scientific's TAXUS Liberte Atom Paclitaxel-Eluting Coronary Stent System is a next-generation drug-eluting stent (DES) specifically designed for treating small coronary vessels....

The CYPHER Sirolimus-eluting Coronary Stent offered by Cordis (a Johnson & Johnson company) was the first drug-eluting stent approved for the U.S. market when it was approved by the FDA in 2003.

...

The GORE Flow Reversal System minimizes the risk of emboli reaching the brain during carotid artery stenting (CAS)....

The Endeavor Sprint drug-eluting stent (DES) is now offered on a rapid exchange (RX) delivery system.
...

Boston Scientific's Carotid WALLSTENT Endoprosthesis is designed for the treatment of patients with carotid artery disease who are at high risk for surgery.

...

IDev Technologies’ SUPERA interwoven nitinol self-expanding stent is designed for palliative treatment of malignant strictures in the biliary tree.

...

The FDA recently cleared Boston Scientific Corp.’s PROMUS Everolimus-Eluting Coronary Stent System.

...

The FDA recently cleared Boston Scientific Corp.’s PROMUS Everolimus-Eluting Coronary Stent System and Abbott Vascular’s XIENCE V Everolimus Eluting Coronary Stent System, both for the treatment of co...

Stentys, a French-based company, will feature its bifurcated stent at TCT 2008.

...

Medtronic Inc. will feature its FDA-cleared Talent Abdominal Stent Graft on the CoilTrac Delivery System for the treatment of abdominal aortic aneurysms.

...

Medtronic Inc. recently announced the initiation of the first investigational sites in the U.S....

OrbusNeich will showcase its Genous Stent at TCT 2008, a stent that was CE Marked in 2005....